Home › Funds › NEA Management Company, LLC › KPTI
NEA Management Company, LLC position in KPTI
KARYOPHARM THERAPEUTICS INC · Health Care
NEA Management Company, LLC reported holding 576,780 shares of KPTI (KARYOPHARM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.6M, representing 0.35% of its reported portfolio and ranking #19 among its reported holdings. NEA Management Company, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's KPTI position evolved
NEA Management Company, LLC first disclosed a stake in KPTI in Q2 2026 at 576,780 shares (US$5.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 576.78K | $5.64M | New |
About KPTI and 13F data
KPTI (KARYOPHARM THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in KPTI — the largest reported positions include ACORN CAPITAL ADVISORS, LLC (US$14.8M), Catalio Capital Management, LP (US$9.2M), Avidity Partners Management LP (US$9.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KPTI
- ACORN CAPITAL ADVISORS, LLC 1.52M sh · $14.83M · Q2 2026
- Catalio Capital Management, LP 940.86K sh · $9.19M · Q2 2026
- Avidity Partners Management LP 924.49K sh · $9.03M · Q2 2026
- Kalehua Capital Management LLC 685.64K sh · $6.70M · Q2 2026
- Tetragon Partners GP Ltd 250.30K sh · $2.45M · Q2 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held KPTI?
NEA Management Company, LLC has disclosed KPTI holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is NEA Management Company, LLC's current position in KPTI?
As of Q2 2026, NEA Management Company, LLC holds 576.78K shares of KPTI (KARYOPHARM THERAPEUTICS INC), valued at $5.64M, representing 0.35% of its reported portfolio and ranking #19.
Has NEA Management Company, LLC been buying or selling KPTI?
In the latest 13F filing (Q2 2026), NEA Management Company, LLC newly opened its position in KPTI.
Which other funds hold KPTI?
Other major institutional holders of KPTI include ACORN CAPITAL ADVISORS, LLC, Catalio Capital Management, LP, Avidity Partners Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.